Paul L. Boyer, Ph.D.
Dr. Paul Boyer is a staff scientist in the HIV Drug Resistance Program.
1) identification and characterization of HIV-1 inhibitors, 2) reverse transcriptase
Selected Recent Publications
Discovery of novel inhibitors of HIV-1 reverse transcriptase through virtual screening of experimental and theoretical ensembles.Chem Biol Drug Des. 83: 521-31, 2014. [ Journal Article ]
- Virology. 444: 241-9, 2013. [ Journal Article ]
HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors.J Virol. 86: 5885-94, 2012. [ Journal Article ]
- Antimicrob Agents Chemother. 55: 2379-89, 2011. [ Journal Article ]
- J Virol. 85: 1655-61, 2011. [ Journal Article ]
Dr. Paul Boyer obtained his Ph.D. in Biochemistry at Michigan State University in 1988. After postdoctoral training in the ABL-Basic Research Program at the NCI-Frederick Cancer Research and Development Center, he was promoted to a Scientist Associate in 1997. Dr. Boyer joined the HIV Drug Resistance Program, National Cancer Institute, as a Staff Scientist in 1998.